Evidence map›Paper›PMID 31850494›Full record

ArticleBioscience reports2020

Live-cell monitoring of protein localization to membrane rafts using protein-fragment complementation.

Maria Merezhko, Emmi Pakarinen, Riikka-Liisa Uronen, Henri J Huttunen

Abstract read
In one paragraph

Article in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria MerezhkoNeuroscience Center, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
Emmi PakarinenNeuroscience Center, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
Riikka-Liisa UronenNeuroscience Center, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.
Henri J HuttunenNeuroscience Center, HiLIFE, University of Helsinki, 00014 Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plasma membrane consists of a variety of discrete domains differing from the surrounding membrane in composition and properties. Selective partitioning of protein to these microdomains is essential for membrane functioning and integrity. Studying the nanoscale size and dynamic nature of the membrane microdomains requires advanced imaging approaches with a high spatiotemporal resolution and, consequently, expensive and specialized equipment, unavailable for most researchers and unsuited for large-scale studies. Thus, understanding of protein partitioning to the membrane microdomains in health and disease is still hampered by the lack of inexpensive live-cell approaches with an appropriate spatial resolution. Here, we have developed a novel approach based on Gaussia princeps luciferase protein-fragment complementation assay to quantitively investigate protein partitioning to cholesterol and sphingomyelin-rich domains, sometimes called 'lipid rafts', in intact living cells with a high-spatial resolution. In the assay, the reporter construct, carrying one half of the luciferase protein, is targeted to lipid microdomains through the fused acetylation motif from Src-family kinase Fyn. A protein of interest carries the second half of the luciferase protein. Together, this serves as a reversible real-time sensor of raft recruitment for the studied protein. We demonstrated that the assay can efficiently detect the dynamic alterations in raft localization of two disease-associated proteins: Akt and APP. Importantly, this method can be used in high-throughput screenings and other large-scale studies in living cells. This inexpensive, and easy to implement raft localization assay will benefit all researchers interested in protein partitioning in rafts.

Indexed as

Biosensing TechniquesMicroscopy, FluorescenceAmyloid beta-Protein PrecursorAnimalsCell Line, TumorHumansLuciferasesMembrane MicrodomainsMicePeptide FragmentsProtein TransportProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fynRecombinant Fusion ProteinsTime FactorsAmyloid beta-Protein PrecursorFYN protein, humanLuciferasesPeptide FragmentsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fynRecombinant Fusion Proteinshigh-throughput screeninglipid microdomainslipid raftsprotein-fragment complementation assay

Identifiers

PMID31850494
PMCPMC6944658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.